Search research articles
Contact Us
Filters
Showing results (1111-1120 of 1,130) with videos related to
Page
of 113
Sort By:
Nature Chemical Biology
|
December 8, 2009
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Darren M Hutt, David Herman, Ana P C Rodrigues, et al.
JAMA Cardiology
|
September 10, 2025
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
Frederick L Ruberg, Sergio Teruya, Stephen Helmke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2025
Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technology (MTN-037)
Ken Ho, Craig Hoesley, Peter L Anderson, et al.
JAMA
|
December 26, 2013
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial
John L Berk, Ole B Suhr, Laura Obici, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
A Comprehensive Enumeration of the Human Proteostasis Network. 2. Components of the Autophagy-Lysosome Pathway
Suzanne Elsasser, Lisa P Elia, Richard I Morimoto, et al.
Nature Genetics
|
January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment context
Cristina Valero, Mark Lee, Douglas Hoen, et al.
Vaccine
|
July 14, 2023
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn
Flor M Munoz, Christine M Posavad, Barbra A Richardson, et al.
Nature Communications
|
February 2, 2021
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
Cristina Valero, Mark Lee, Douglas Hoen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2024
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non-Small-Cell Lung Cancer
Arielle Elkrief, Meagan Montesion, Smruthy Sivakumar, et al.
Nature Genetics
|
July 11, 2022
Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity
Xiaoxiao Ma, Nadeem Riaz, Robert M Samstein, et al.
Page
of 113
Search research articles
Search
Showing results (1111-1120 of 1,130) with videos related to
Sort By:
Page
of 113
Nature Chemical Biology
|
December 8, 2009
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Darren M Hutt, David Herman, Ana P C Rodrigues, et al.
JAMA Cardiology
|
September 10, 2025
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
Frederick L Ruberg, Sergio Teruya, Stephen Helmke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2025
Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technology (MTN-037)
Ken Ho, Craig Hoesley, Peter L Anderson, et al.
JAMA
|
December 26, 2013
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial
John L Berk, Ole B Suhr, Laura Obici, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
A Comprehensive Enumeration of the Human Proteostasis Network. 2. Components of the Autophagy-Lysosome Pathway
Suzanne Elsasser, Lisa P Elia, Richard I Morimoto, et al.
Nature Genetics
|
January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment context
Cristina Valero, Mark Lee, Douglas Hoen, et al.
Vaccine
|
July 14, 2023
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn
Flor M Munoz, Christine M Posavad, Barbra A Richardson, et al.
Nature Communications
|
February 2, 2021
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
Cristina Valero, Mark Lee, Douglas Hoen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2024
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non-Small-Cell Lung Cancer
Arielle Elkrief, Meagan Montesion, Smruthy Sivakumar, et al.
Nature Genetics
|
July 11, 2022
Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity
Xiaoxiao Ma, Nadeem Riaz, Robert M Samstein, et al.
Page
of 113